Surgery Partners, Inc. announced a significant financing event, amending its credit agreement to secure a new tranche of term loans totaling US$1.38 billion. This refinancing initiative is designed to bolster the company's financial flexibility and operational stability.
The new term loans are expected to support Surgery Partners' ongoing growth initiatives and provide capital for future strategic endeavors. This move is part of the company's broader strategy to manage its corporate debt structure, which includes $2.2 billion outstanding with no maturities until 2030.
The refinancing aims to optimize the company's capital structure, potentially impacting its ability to fund internal growth and pursue accretive acquisitions. Management is focused on reducing its Credit Agreement net debt-to-EBITDA ratio, targeting around 3x by the end of 2025.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.